合理设计的合作增强受体可以放大水中的宿主-客体结合
Roshan W Gunasekara1, Yan Zhao
1Department of Chemistry, Iowa State University , Ames, Iowa 50011-3111, United States.
Journal of the American Chemical Society
|December 23, 2014
概括
研究人员设计了合成受体,通过解决内部冲突来增强结合能量. 这一突破使得强大而有选择性的分子识别成为可能,克服了设计人工生物相互作用的挑战.
科学领域:
- 超分子化学 超分子化学
- 化学生物学 化学生物学
- 材料科学 材料科学 材料科学
背景情况:
- 生物受体利用客体诱导的相互作用来增强结合能量.
- 这些受体的合成模仿因复杂的相互作用要求而具有挑战性.
- 在合成受体设计中,内部静电和疏水相互作用经常发生冲突.
研究的目的:
- 设计合成受体,在客结合时激活内部相互作用.
- 为了克服合成受体中的"静电丧",使用互补的客户端设计.
- 在人工宿主-客户系统中实现高结合亲和力和选择性.
主要方法:
- 设计的合成受体具有相互冲突的静电和疏水相互作用要求.
- 设计了互补的客人来解决这些内部冲突 ("静电丧").
- 使用氨基碳酸盐桥梁来调解主机与客人的互动.
主要成果:
- 在客结合时成功激活了内受体相互作用,有助于结合能量.
- 达到了超过10^5 M^-1的结合常数 (Ka),证明了强大的结合.
- 在分子识别中观察到优异的选择性,即使具有灵活的受体结构.
结论:
- 工程冲突相互作用允许客人控制的内接收器力量的激活.
- 这一策略使得能够设计具有高度亲和力和选择性的合成受体.
- 开发的方法克服了水性环境中的传统盐桥相互作用的局限性.
相关概念视频
Ligand Binding Sites
15.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.9K
Drug-Receptor Bonds
5.5K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
5.5K
Quantitative Aspects of Drug-Receptor Interaction
2.3K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.3K
The Two-State Receptor Model
3.6K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.6K
Complexometric Titration: Ligands
2.7K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.7K
Cooperative Allosteric Transitions
9.5K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.5K


